Quantcast

Industry news that matters to you.  Learn more

Archives for December 2013

NanoString Launches the nCounter Dx Analysis System for U.S. Market

NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecular diagnostic products, recently announced the availability of the nCounter® Dx Analysis System for high-complexity, CLIA-certified laboratories. 

Use of Biomarkers in Clinical Trials for Drugs Outside of Oncology is Increasing

Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that while most of the biomarker-drug success stories are in oncology, biomarkers play a critical role in pharmaceutical development of chronic conditions, and their use in clinical trials of drugs outside of oncology is building. 

Advanced Cell Diagnostics Announces Genoptix as their First CLIA Certified RNAscope Service Provider

Advanced Cell Diagnostics, Inc., a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, today announced that it has introduced a CLIA Certified RNAscope Service Provider program, with Genoptix BioPharma Services, as the first to be certified.

Global CEO Initiative on Alzheimer’s Disease Announces a Big Data Challenge to Find New Predictors of Cognitive Decline

The Global CEO Initiative (CEOi) on Alzheimer’s Disease, Sage Bionetworks, and IBM’s DREAM, recently announced the Alzheimer’s Disease Big Data (AD#1) Challenge at the Alzheimer’s Disease Summit: The Path to 2025.

Boehringer Ingelheim to Sponsor the Bonnie J. Addario Lung Cancer Foundation’s Efforts to Promote Genetic Biomarker Testing

The Bonnie J. Addario Lung Cancer Foundation (ALCF) and Boehringer Ingelheim Pharmaceuticals, Inc. (BI) recently announced that BI will sponsor ALCF’s efforts to raise awareness about the importance of immediate genetic biomarker testing for patients with advanced non-small cell lung cancer (NSCLC).